96 related articles for article (PubMed ID: 2656331)
41. Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review.
Fritz H; Kennedy DA; Ishii M; Fergusson D; Fernandes R; Cooley K; Seely D
Integr Cancer Ther; 2015 May; 14(3):201-11. PubMed ID: 25784670
[TBL] [Abstract][Full Text] [Related]
42. [Treatment of tumors of the urinary bladder with so-called immunopotentiators].
Tsujimura S; Kato J; Ueda K; Ohtaguro K
Hinyokika Kiyo; 1983 Jan; 29(1):9-15. PubMed ID: 6677093
[TBL] [Abstract][Full Text] [Related]
43. Protective effect of PSK, a protein-bound polysaccharide preparation against candidiasis in tumor-bearing mice.
Uetsuka A; Satoh S; Ohno Y
Adv Exp Med Biol; 1979; 121B():21-31. PubMed ID: 546134
[TBL] [Abstract][Full Text] [Related]
44. Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters.
Ohwada S; Ogawa T; Makita F; Tanahashi Y; Ohya T; Tomizawa N; Satoh Y; Kobayashi I; Izumi M; Takeyoshi I; Hamada K; Minaguchi S; Togo Y; Toshihiko T; Koyama T; Kamio M
Oncol Rep; 2006 Apr; 15(4):861-8. PubMed ID: 16525672
[TBL] [Abstract][Full Text] [Related]
45. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns.
Leung TW; Tung SY; Sze WK; Wong FC; Yuen KK; Lui CM; Lo SH; Ng TY; O SK
Head Neck; 2005 Jul; 27(7):555-65. PubMed ID: 15880410
[TBL] [Abstract][Full Text] [Related]
46. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
Low JS; Chua ET; Gao F; Wee JT
Head Neck; 2006 Apr; 28(4):321-9. PubMed ID: 16287135
[TBL] [Abstract][Full Text] [Related]
47. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
[TBL] [Abstract][Full Text] [Related]
48. [A randomized controlled study of PSK combined immuno-chemotherapy for adenocarcinoma of the lung. The Advanced Lung Cancer Immuno-chemotherapy Study Group].
Nishiwaki Y; Furuse K; Fukuoka M; Ota M; Niitani H; Asakawa M; Nakai H; Sakai S; Ogawa N
Gan To Kagaku Ryoho; 1990 Jan; 17(1):131-6. PubMed ID: 2404455
[TBL] [Abstract][Full Text] [Related]
49. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
Margel D; Tal R; Golan S; Kedar D; Engelstein D; Baniel J
Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
[TBL] [Abstract][Full Text] [Related]
50. [Multi-institutional cooperative study of adjuvant immunochemotherapy in gastric cancer--five-year survival rate].
Nakajima T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondou T; Abe O; Kikuchi K; Tanabe T; Ogawa N
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):799-806. PubMed ID: 2496668
[TBL] [Abstract][Full Text] [Related]
51. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
52. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
[TBL] [Abstract][Full Text] [Related]
53. Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN(®)): review of development and future perspectives.
Maehara Y; Tsujitani S; Saeki H; Oki E; Yoshinaga K; Emi Y; Morita M; Kohnoe S; Kakeji Y; Yano T; Baba H
Surg Today; 2012 Jan; 42(1):8-28. PubMed ID: 22139128
[TBL] [Abstract][Full Text] [Related]
54. In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer.
Sugimachi K; Maehara Y; Kusumoto T; Okamura T; Korenaga D; Kohnoe S; Baba H; Anai H
Anticancer Res; 1995; 15(5B):2175-9. PubMed ID: 8572620
[TBL] [Abstract][Full Text] [Related]
55. Effects of PSK, an antitumor protein-bound polysaccharide, on the surface charge of lymphocytes in X5563-bearing mice.
Hayashi H; Fujii T; Fujii M; Yoshikumi C; Kawai Y; Shimizu M; Iwaguchi T
J Clin Lab Immunol; 1987 Sep; 24(1):33-7. PubMed ID: 3681950
[TBL] [Abstract][Full Text] [Related]
56. [Effectiveness of multidisciplinary treatment combined with immunotherapy in esophageal cancer--analysis of 287 cases of carcinoma of the thoracic part of the esophagus in Kyushu and Yamaguchi districts].
Sugimachi K; Miyauchi Y; Inutsuka S; Kakegawa T; Nishi M; Tomita M; Koga Y; Ishigami K; Inokuchi K
Gan No Rinsho; 1987 Jun; 33(7):777-83. PubMed ID: 3613103
[TBL] [Abstract][Full Text] [Related]
57. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
58. [A four-year follow-up study of hepatocellular carcinoma with bone metastasis].
Matsuzaki T; Nakashima Y; Ikegami M; Okubo H; Hino K; Emura T; Shinkawa G; Hirai K; Abe H; Tanikawa K
Gan No Rinsho; 1989 Nov; 35(14):1673-80. PubMed ID: 2556588
[TBL] [Abstract][Full Text] [Related]
59. [Induction of manganese superoxide dismutase by an immunopotentiator as a mechanism of inhibiting of malignant progression of murine tumor cells].
Habelhah H
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):519-29. PubMed ID: 9846281
[TBL] [Abstract][Full Text] [Related]
60. A comparative study of locoregionally advanced nasopharyngeal carcinoma treated with intensity modulated irradiation and platinum-based chemotherapy.
Xu JH; Guo WJ; Bian XH; Wu JF; Jiang XS; Guo YS; He X
Cancer Radiother; 2013; 17(4):297-303. PubMed ID: 23849438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
